Browsing: drug
Premier consultancy McKinsey & Company is under investigation by the US Department of Justice for its past work advising opioid…
Biogen on Wednesday reported first-quarter profit that topped estimates as the company’s cost-cutting efforts took hold and sales of its…
CHICAGO (Reuters) – Nine months into the U.S. launch of the first drug proven to slow the advance of Alzheimer’s,…
By Nate Raymond and Dan Whitcomb BOSTON (Reuters) -The U.S. Justice Department on Wednesday accused Regeneron (NASDAQ:) Pharmaceuticals of manipulating…
President Joe Biden teamed up Wednesday with Sen. Bernie Sanders, his one-time 2020 Democratic primary rival and a leader in Congress’ progressive wing,…
Oregon Gov. Tina Kotek signed legislation on Monday re-criminalizing the possession of certain drugs, roughly three years after the state became the first…
Scientists in the United States, especially those in the biomedical fields, are increasingly leaving the world of academia for better-paying…
By Patrick Wingrove (Reuters) – Gerresheimer CEO Dietmar Siemssen said he expects about 4% of the company’s revenue growth per…
Robert Mazur tells the full story of his time as a government agent investigating drug-money laundering. Mazur went undercover for…
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time…